Christine Matthews - 15 Oct 2021 Form 4 Insider Report for Zosano Pharma Corp

Role: Chief Financial Officer
Signature: /s/ Steve Lo, as Attorney in Fact for Christine Matthews
Issuer symbol: N/A
Transactions as of: 15 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 19 Oct 2021, 21:35:20 UTC
Previous filing: 07 Jun 2021
Next filing: 01 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZSAN	Common Stock	Award	$0	+56,250	+57%	$0.000000	154,541	15 Oct 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZSAN	Stock Option (Right to Buy)	Award	$0	+112,500		$0.000000	112,500	15 Oct 2021	Common Stock	112,500	$0.6342	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the completion of performance vesting.
F2	Includes 56,250 RSUs which are subject to performance vesting.
F3	The shares subject to the stock option vest and become exercisable in accordance with a performance vesting schedule.